Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

A Phase 3 Trial of Thymoglobuline for Prevention of Chronic Gvhd in Transplantation from an HLA-Matched Sibling

Gi June Min, MD, Byung Sik Cho, MD, PhD, Sung-Soo Park, MD, PhD, Silvia Park, MD PhD, Seung-Ah Yahng, MD, PhD, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD PhD, Ki-Seong Eom, MD, PhD, Yoo-Jin Kim, MD, PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD, PhD, Dong-Wook Kim, MD, Jong Wook Lee, MD, PhD, Heeje Kim, MD PhD, Seok Lee, MD, PhD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-139234

Published: 2020

Journal Articles

Physical and Psychological Impairments As Practical Frailty Markers in Elderly AML Fit for Intensive Chemotherapy; Interim Data of a Prospective Cohort Study

GI June MIN, MD, Byung Sik Cho, MD PhD, Sung-Soo Park, MD, Silvia Park, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD PhD, Seung-Ah Yahng, MD PhD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Seok-Goo Cho, MD PhD, Chang-Ki Min, MD PhD, Dong-Wook Kim, Jong-Wook Lee, MD PhD, Hee-Je Kim, MD PhD

Blood (2019) 134 (Supplement_1): 3831.

https://doi.org/10.1182/blood-2019-123584

Published: 2019

Journal Articles

Comparison of Myeloablative (CyTBI, BuCy) Versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Low WT1 Expression Level at Transplant

Silvia Park, GI June MIN, MD, Sung-Soo Park, Seung-Ah Yahng, MD PhD, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD PhD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD, Byung-Sik Cho, MD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Chang Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, Jong-Wook Lee, MD PhD, Hee-Je Kim, MD PhD

Blood (2019) 134 (Supplement_1): 1973.

https://doi.org/10.1182/blood-2019-128306

Published: 2019

Journal Articles

Clinical Implications of Copy Number Variant Detection from Panel-Based Next-Generation Sequencing Data in Myelodysplastic Syndrome

Je-Hwan Lee, MD PhD, Yoo-Jin Kim, MD PhD, Seung-Hyun Jung, Eun-Hye Hur, Eun-Ji Choi, MD, Kyoo Hyung Lee, MD PhD, Seon-Hee Yim, Hye-Jung Kim, Yong-Rim Kwon, Young-Woo Jeon, MD PhD, Sug Hyung Lee, Yeun-Jun Chung

Blood (2019) 134 (Supplement_1): 4264.

https://doi.org/10.1182/blood-2019-131570

Published: 2019

Journal Articles

Validation of Recently Proposed Risk and Prognostic Factors for Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Gi June Min, MD, Hee-Je Kim, MD PhD, Sung-Soo Park, MD, Silvia Park, Young-Woo Jeon, MD PhD, Seung-Ah Yahng, MD PhD, Seung-Hwan Shin, MD PhD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD, Byung Sik Cho, MD PhD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, Jong-Wook Lee, MD PhD

Blood (2019) 134 (Supplement_1): 3260.

https://doi.org/10.1182/blood-2019-124275

Published: 2019

Journal Articles

Genetic Characteristics and Long-Term Outcomes of Korean Adult Patients with Ph-like Acute Lymphoblastic Leukemia Versus Non-Ph-like Acute Lymphoblastic Leukemia

Jae-Ho Yoon, MD PhD, Hanwool Cho, Seug Yun Yoon, MD, Gi June Min, MD, Sung-Soo Park, MD, Silvia Park, MD PhD, Young-Woo Jeon, MD PhD, Sung-Eun Lee, MD PhD, Byung-Sik Cho, MD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Hee-Je Kim, MD PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD PhD, Myungshin Kim, MD PhD, Yonggoo Kim, Seok Lee, MD PhD

Blood (2018) 132 (Supplement 1): 4087.

https://doi.org/10.1182/blood-2018-99-118067

Published: 2018

Journal Articles

Measurable Residual Disease Assay with WT1 Expression in Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation; Optimal Threshold, Time Points, and Candidates

Byung Sik Cho, MD PhD, GI June MIN, MD, Heeje Kim, MD PhD, Seug Yun Yoon, MD, Sung-Soo Park, MD, Silvia Park, MD PhD, Seung-Ah Yahng, MD PhD, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD PhD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD PhD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD PhD

Blood (2018) 132 (Supplement 1): 2759.

https://doi.org/10.1182/blood-2018-99-110042

Published: 2018

Journal Articles

Natural-Killer Cell Cytotoxicity and Interleukin-2R As a Relevant Marker for Diagnosis of Secondary Hemophagocytic Lymphohistiocytosis in Adult Patients: The Results of Prospective Phase II Observational Study

Jae-Ho Yoon, MD PhD, Ki Hyun Park, Seug Yun Yoon, MD, GI June MIN, MD, Sung-Soo Park, MD, Young-Woo Jeon, MD PhD, Sung-Eun Lee, MD PhD, Byung Sik Cho, MD PhD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Hee-Je Kim, MD PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD PhD, Eun-Jee Oh

Blood (2018) 132 (Supplement 1): 4939.

https://doi.org/10.1182/blood-2018-99-118537

Published: 2018

Journal Articles

Specific Donor Human Leukocyte Antigen (HLA) Allotypes and CMV IgG Serology Status Predict the Risk of Cytomegalovirus-Related Disease in Acute Myeloid Leukemia Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2018) 132 (Supplement 1): 2076.

https://doi.org/10.1182/blood-2018-99-113233

Published: 2018

Journal Articles

The Role of Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells in Allogeneic Hematopoietic Stem Cell Transplantation

Sung-Eun Lee, MD, Ji-Young Lim, Tae Woo Kim, Young-Woo Jeon, MD, Jae-Ho Yoon, MD PhD, Byung-Sik Cho, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min, Dong-Mi Shin, Eun Young Choi, Chang-Ki Min, MD

Blood (2017) 130 (Supplement 1): 3234.

https://doi.org/10.1182/blood.V130.Suppl_1.3234.3234

Published: 2017

Journal Articles

Development of Prognostic Prediction Model for Decision of Secondary Allogeneic Stem Cell Transplantation for Relapsed Acute Myeloid Leukemia after First Stem Cell Transplantation

Sung-Soo Park, Heeje Kim, MD PhD, Dae Hun Kwak, Gi June Min, MD, Young-Woo Jeon, MD, Jae-Ho Yoon, MD PhD, Seung-Hwan Shin, Seung-Ah Yahng, Sung-Eun Lee, MD, Byung-Sik Cho, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Seok Lee, Chang-Ki Min, MD, Seok-Goo Cho, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min

Blood (2017) 130 (Supplement 1): 3279.

https://doi.org/10.1182/blood.V130.Suppl_1.3279.3279

Published: 2017

Journal Articles

Improved Survival Outcomes By Iron Chelating Therapy with Deferasirox after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Byung Sik Cho, MD PhD, Young-Woo Jeon, MD, Sung-Soo Park, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min, Heeje Kim, MD PhD

Blood (2017) 130 (Supplement 1): 3207.

https://doi.org/10.1182/blood.V130.Suppl_1.3207.3207

Published: 2017

Journal Articles

Risk Factors Predicting Graft-Versus-Host Disease and Relapse-Free Survival (GRFS) after Allogeneic Hematopoietic Stem Cell Transplantation in Relapse/Refractory Non-Hodgkin Lymphomas

Young-Woo Jeon, MD, Sung-Soo Park, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Hee-Je Kim, Seok Lee, MD PhD, Jong-Wook Lee, MD, Seok-Goo Cho, MD PhD

Blood (2017) 130 (Supplement 1): 2055.

https://doi.org/10.1182/blood.V130.Suppl_1.2055.2055

Published: 2017

Journal Articles

the Clinical Impact of Impaired Natural-Killer Cell Cytotoxicity for Diagnosis and Prognostication in Adult Patients with Febrile Cytopenia Including Hemophagocytic Lymphohistiocytosis and Similar Diseases: The Results of Prospective Phase II Observational Study

Jae-Ho Yoon, MD PhD, Sung-Soo Park, Young-Woo Jeon, MD, Sung-Eun Lee, MD, Byung-Sik Cho, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Hee-Je Kim, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min, Eun-Jee Oh

Blood (2017) 130 (Supplement 1): 3581.

https://doi.org/10.1182/blood.V130.Suppl_1.3581.3581

Published: 2017

Journal Articles

Long-Term Follow-up on Adult Patients with Philadelphia-Chromosome Positive Acute Myeloid Leukemia Who Were Treated with Interim Imatinib Followed By Allogeneic Hematopoietic Cell Transplantation

Heeje Kim, MD PhD, Gi June Min, MD, Jae-Ho Yoon, MD PhD, Sung-Soo Park, Young-Woo Jeon, MD, Sung-Eun Lee, MD, Byung-Sik Cho, MD, Ki-Sung Eom, Yoo-Jin Kim, MD PhD, Seok Lee, Chang-Ki Min, MD, Seok-Goo Cho, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min

Blood (2017) 130 (Supplement 1): 2030.

https://doi.org/10.1182/blood.V130.Suppl_1.2030.2030

Published: 2017

Journal Articles

Durable Outcomes of a Prospective Double Cord Blood Transplantation Trial in Adults with Acute Lymphoblastic Leukemia: Different Outcomes According to the Presence of Philadelphia Chromosome

Jae-Ho Yoon, MD PhD, Sung-Soo Park, Young-Woo Jeon, MD, Sung-Eun Lee, MD, Byung-Sik Cho, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Hee-Je Kim, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min, Seok Lee, MD PhD

Blood (2017) 130 (Supplement 1): 2550.

https://doi.org/10.1182/blood.V130.Suppl_1.2550.2550

Published: 2017

Journal Articles

Impact of Donor Type on Long-Term Outcomes of Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia during First Remission

Blood (2017) 130 (Supplement 1): 2551.

https://doi.org/10.1182/blood.V130.Suppl_1.2551.2551

Published: 2017

Journal Articles

Robust Production of Cytomegalovirus pp65-Specific T Cells By a Fully Automated IFN-γ Cytokine Capture System

Nayoun Kim, PhD, Young-Sun Nam, Keon-Il Im, PhD, Jung-Yeon Lim, Young-Woo Jeon, MD, YuneJin Song, Jong Wook Lee, MD PhD, Seok-Goo Cho

Blood (2016) 128 (22): 5739.

https://doi.org/10.1182/blood.V128.22.5739.5739

Published: 2016

Journal Articles

Improved Outcomes of Low-Dose Cytarabine Regimen By Increased Dose and Duration of Cytarabine in Combination with Oral Etoposide for Elderly Acute Myeloid Leukemia

Seung-Hwan Shin, MD, Seung-Ah Yahng, MD, Jae-Ho Yoon, MD, Byung-Sik Cho, MD, Hee-Je Kim, MD, Young-Woo Jeon, MD, Sung-Eun Lee, MD, Ki-Sung Eom, MD, Yoo-Jin Kim, MD, Seok Lee, MD, Chang-Ki Min, MD, Seok-Goo Cho, MD, Dong-Wook Kim, Jong-Wook Lee, MD, Woo-Sung Min, MD

Blood (2015) 126 (23): 1338.

https://doi.org/10.1182/blood.V126.23.1338.1338

Published: 2015

NARROW

A Phase 3 Trial of Thymoglobuline for Prevention of Chronic Gvhd in Transplantation from an HLA-Matched Sibling

Physical and Psychological Impairments As Practical Frailty Markers in Elderly AML Fit for Intensive Chemotherapy; Interim Data of a Prospective Cohort Study

Comparison of Myeloablative (CyTBI, BuCy) Versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Low WT1 Expression Level at Transplant

Clinical Implications of Copy Number Variant Detection from Panel-Based Next-Generation Sequencing Data in Myelodysplastic Syndrome

Validation of Recently Proposed Risk and Prognostic Factors for Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Genetic Characteristics and Long-Term Outcomes of Korean Adult Patients with Ph-like Acute Lymphoblastic Leukemia Versus Non-Ph-like Acute Lymphoblastic Leukemia

Measurable Residual Disease Assay with WT1 Expression in Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation; Optimal Threshold, Time Points, and Candidates

Natural-Killer Cell Cytotoxicity and Interleukin-2R As a Relevant Marker for Diagnosis of Secondary Hemophagocytic Lymphohistiocytosis in Adult Patients: The Results of Prospective Phase II Observational Study

Specific Donor Human Leukocyte Antigen (HLA) Allotypes and CMV IgG Serology Status Predict the Risk of Cytomegalovirus-Related Disease in Acute Myeloid Leukemia Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation

The Role of Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells in Allogeneic Hematopoietic Stem Cell Transplantation

Development of Prognostic Prediction Model for Decision of Secondary Allogeneic Stem Cell Transplantation for Relapsed Acute Myeloid Leukemia after First Stem Cell Transplantation

Improved Survival Outcomes By Iron Chelating Therapy with Deferasirox after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Risk Factors Predicting Graft-Versus-Host Disease and Relapse-Free Survival (GRFS) after Allogeneic Hematopoietic Stem Cell Transplantation in Relapse/Refractory Non-Hodgkin Lymphomas

the Clinical Impact of Impaired Natural-Killer Cell Cytotoxicity for Diagnosis and Prognostication in Adult Patients with Febrile Cytopenia Including Hemophagocytic Lymphohistiocytosis and Similar Diseases: The Results of Prospective Phase II Observational Study

Long-Term Follow-up on Adult Patients with Philadelphia-Chromosome Positive Acute Myeloid Leukemia Who Were Treated with Interim Imatinib Followed By Allogeneic Hematopoietic Cell Transplantation

Durable Outcomes of a Prospective Double Cord Blood Transplantation Trial in Adults with Acute Lymphoblastic Leukemia: Different Outcomes According to the Presence of Philadelphia Chromosome

Impact of Donor Type on Long-Term Outcomes of Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia during First Remission

Robust Production of Cytomegalovirus pp65-Specific T Cells By a Fully Automated IFN-γ Cytokine Capture System

Improved Outcomes of Low-Dose Cytarabine Regimen By Increased Dose and Duration of Cytarabine in Combination with Oral Etoposide for Elderly Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only